← Back to directory
Not currently recruitingFunding unknown
- Works count
- 52
- Citation count
- 3,763
- H-index
- 10
- i10-index
- 10
Research interests
Medicine
Cancer Immunotherapy and Biomarkers
Lung Cancer Treatments and Mutations
HER2/EGFR in Cancer Research
Head and Neck Cancer Studies
Cutaneous Melanoma Detection and Management
Publications
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
The Lancet · 2019 · 10.1016/s0140-6736(18)32409-7
Current projects
No projects listed.